SCHEMBL3024837

SCHEMBL3024837

C/C(=C/C(=O)O)c1ccc(NC(=S)c2cc([Si](C)(C)C)cc([Si](C)(C)C)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.40
NR4A2 P43354 1/20 0.40
NR4A3 Q92570 1/20 0.40
DEGS1 O15121 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.36
TBXAS1 P24557 2/20 0.36
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 5/20 0.34
MAPT P10636 4/20 0.34
KDM4E B2RXH2 3/20 0.34
TRPV1 Q8NER1 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
TAAR1 Q96RJ0 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3024833 1.00 NR4A1 (0.40) NR4A1NR4A2NR4A3DEGS1SMN1; SMN2
SCHEMBL3024838 1.00 NR4A1 (0.40) NR4A1NR4A2NR4A3DEGS1SMN1; SMN2
SCHEMBL3019605 0.87 CACNA1B (0.43) NR4A1NR4A2NR4A3DEGS1NPC1
SCHEMBL3019610 0.87 CACNA1B (0.43) NR4A1NR4A2NR4A3DEGS1NPC1
SCHEMBL3019608 0.87 CACNA1B (0.43) NR4A1NR4A2NR4A3DEGS1NPC1
SCHEMBL18123264 0.84 ALDH1A1 (0.49) SMN1; SMN2NPC1RAB9AHPGDALDH1A1
SCHEMBL3019704 0.80 ITGB3 (0.42) NPC1RAB9AHPGDALDH1A1MAPT
SCHEMBL3019706 0.80 ITGB3 (0.42) NPC1RAB9AHPGDALDH1A1MAPT
SCHEMBL20045013 0.77 KMT2A (0.38) NR4A1NR4A2NR4A3DEGS1SMN1; SMN2
SCHEMBL3012184 0.74 NR1H4 (0.48) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7855300-B2 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2010-12-21 US disclosed
US-20100210591-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 2010-08-19 US disclosed
EP-2202235-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210591-A1 BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF RARA, RARB, RXRA NR4A1 30/4885NR4A2 35/4885NR4A3 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.